Ian Robins
Professor
600 Highland Avenue
K4/B100
Madison, WI 53792
Telephone: 608-263-8500
Fax: N/A
E-mail:
Medical School: Boston University
Internship: UW Hospital and Clinics
Residency: UW Hospital and Clinics
Fellowship: UW Comprehensive Cancer Center
Board certifications: Internal Medicine, Medical Oncology
Search PubMed for my publications
Katschinski, D.M., Robins, H.I. Hyperthermic modulation of SN-38-induced cleavable complex formation and cytotoxicity through altered topoisomerase I activity. Int. J. of Cancer: 80: 104-109, 1999.
Robins, H.I., Katschinski, D.M., Longo, W., Grosen, E., Wilding, G., Gillis, W., Kraemer, C., Tiggelaar, C.L., Rushing, D., Stewart, J.A., Spriggs, D., Love, R., Arzoomanian, R.Z., Feieabend, C., Alberti, D., Morgan, K., Simon, K., d'Oleire, F. A Pilot Study of Melphalan, Tumor Necrosis Factor-a and 41.8°C Whole Body Hyperthermia. Cancer Chemotherapy and Pharmacology: (43) 409-414, 1999.
Chang, S.M., Kuhn, J.G., Robins, H.I., Schold, S.C., Spence, A.M., Berger, M.S., Mehta, M.P., Bozik, M.E., Pollack, I., Schiff, D., Gilbert, M., Rankin, C., Prados, M.D. A phase II Study of phenylacetate in patients with recurrent malignant glioma: A North American Brain Tumor Consortium Report. J. Clin. Oncol. 17(3): 984-990, 1999.
Katschinski, D.M., Wiedemann, G.J., d'Oleire, F.R., Longo, W., Robins, H.I. Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy. Cytokine and Growth Factor Reviews: 10: 93-97, 1999.
Robins, H.I., Grosen, E.G., Katschinski, D.M., Longo, W., Tiggelaar, C.L., Kutz, M., Winawer, J., Graziano, F. Whole body hyperthermia induction of soluble tumor necrosis factor receptors: Implications for Rheumatoid Diseases. J. Rheumatology: 26:2513-2516, 1999.
Katschinski, D.M., Robins, H.I., Schad, M., Frede, S., Fandrey, J. Role of TNFa in hyperthermia-induced apoptosis of human leukemia cells. Cancer Res: 59:3404-3410, 1999.
Robins, H.I., Tutsch, K., Katschinski, D.M., Mehta, M., Jacobson, E., Olsen, M., Cohen, J.D., Tiggelaar, C.L., Arzoomanian, R.Z., Alberti, D., Feierabend, C., Wilding, G. A Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer. J. Clin. Oncol: 17:2922-2931, 1999.
Gerke, P., Wojciech, F., Robins, H.I., Wiedemann, G.J., Steinhoff, J. Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant heat induced whole body hyperthermia. J. Cancer Res Clin Oncol, 126: 173-177, 2000.
Sanghavi, S. Skrupski, R., Badie, B., Robins, H.I., Tome, W., Mehta, M.P. Recurrent malignant glioma treated with Radiosurgery. J. Radiosurg 2:119-125, 2000.
Robins, H.I., Howard, S.P., Mehta, M.P., Validity of Datasets Questioned in gliadel study. Managed Care & Cancer, 2(4):10, 2000.
Schold, S.C., Jr., Kuhn, J.G., Chang, S.M., Bosik, M.E., Robins, H.I., Mehta, M.P., Spence, A.M., Fulton, D., Fink, K.L., Prados, M.D. A phase I trial of 1,3-bis(2-chloroethyl)- nitrosourea plus temozolomide: A North American Brain Tumor Consortium Study. Neuro-Oncology, P. 34, 2000.
Katschinski, D.M., Jacobson, E.L., Wiedeman, G.J., Robins, H.I., Modulation of VP-16 cytotoxicity by carboplatin and 41.8° C hyperthermia. Cancer Res & Clin Oncol., 2001, 127: 425-432.
Westerman, A.M., Grosen, E.A., Katschinski, D.M., Jager, D., Rietbroek, R., Schink, J.C., Tigglar, C.L., Jager, E., Vorde sive Vording P.Z., Neuman, A., Knuth, A., Van Dijk, J.D.P., Wiedeman G.J., Robins, H.I. A pilot Study of Whole Body Hyperthermia nad Carboplatin in Platinum Residant Ovarian. Eur J Cancer. 2001. 37:1111-1117.
Chang S.M., Kuhn, J.G., Robins, H.I., Schold, S.C., Jr, Spence, A.M., Berger, M.S., Mehta, M.P., Pollack, I., Rankin, C., Prados, M.D. A phase II study of paclitacel (Taxol) using different doses depending on the concomitant use of anticonvulsants, in patients with recurrent malignant glioma. A North American Brain Tumor Consortium Report. Cancer, 91:417-22, 2001.
Breast cancer, clinical hypnosis, lymphomas - low grade, malignant melanoma, neuro-oncology, sarcomas, systemic hyperthermia
